like pls_老虎社区_美港股上老虎

xtina
2021-11-11

like pls

Merck says making progress on meeting surge in lab gear demand

Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufact

Merck says making progress on meeting surge in lab gear demand

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":870252744,"tweetId":"870252744","gmtCreate":1636625626208,"gmtModify":1636625626346,"author":{"id":3577237607642633,"idStr":"3577237607642633","authorId":3577237607642633,"authorIdStr":"3577237607642633","name":"xtina","avatar":"https://static.tigerbbs.com/16543fdb93320cc8ed761026d84d34d8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>like pls</p></body></html>","htmlText":"<html><head></head><body><p>like pls</p></body></html>","text":"like pls","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/870252744","repostId":1112610633,"repostType":4,"repost":{"id":"1112610633","kind":"news","pubTimestamp":1636625144,"share":"https://www.laohu8.com/m/news/1112610633?lang=&edition=full","pubTime":"2021-11-11 18:05","market":"us","language":"en","title":"Merck says making progress on meeting surge in lab gear demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1112610633","media":"Reuters","summary":"Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufact","content":"<p>Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufacturing supplies, said the order book in COVID-19 related lab gear was still growing faster than sales but it was getting a better handle on the situation.</p>\n<p>\"We are really very well trained at this time to deal with the supply chain pressures... We have made tremendous progresses, however, our order book is still growing faster than our sales,\" Chief Executive Belen Garijo told journalists after releasing full quarterly results.</p>\n<p>\"We are getting the situation back on track but it’s going to take a little bit of time to get each and every site up to the necessary targets to be able to fulfil 100% of customer demand,\" she said, adding that only single-use bioreactor equipment and filters were affected.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck says making progress on meeting surge in lab gear demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck says making progress on meeting surge in lab gear demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 18:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-making-progress-meeting-surge-lab-gear-demand-2021-11-11/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufacturing supplies, said the order book in COVID-19 related lab gear was still growing faster than sales...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-making-progress-meeting-surge-lab-gear-demand-2021-11-11/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-making-progress-meeting-surge-lab-gear-demand-2021-11-11/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112610633","content_text":"Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufacturing supplies, said the order book in COVID-19 related lab gear was still growing faster than sales but it was getting a better handle on the situation.\n\"We are really very well trained at this time to deal with the supply chain pressures... We have made tremendous progresses, however, our order book is still growing faster than our sales,\" Chief Executive Belen Garijo told journalists after releasing full quarterly results.\n\"We are getting the situation back on track but it’s going to take a little bit of time to get each and every site up to the necessary targets to be able to fulfil 100% of customer demand,\" she said, adding that only single-use bioreactor equipment and filters were affected.","news_type":1},"isVote":1,"tweetType":1,"viewCount":832,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Merck says making progress on meeting surge in lab gear demand

评论（2）

热议股票